monday.com (NASDAQ:MNDY – Get Free Report) and OneMedNet (NASDAQ:ONMD – Get Free Report) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, profitability, institutional ownership, dividends and risk.
Profitability
This table compares monday.com and OneMedNet’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| monday.com | 9.17% | 5.10% | 2.91% |
| OneMedNet | -254.13% | N/A | -383.90% |
Volatility and Risk
monday.com has a beta of 1.24, suggesting that its share price is 24% more volatile than the S&P 500. Comparatively, OneMedNet has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| monday.com | $1.30 billion | 2.79 | $118.74 million | $2.30 | 30.81 |
| OneMedNet | $1.32 million | 26.10 | -$2.80 million | ($0.05) | -12.64 |
monday.com has higher revenue and earnings than OneMedNet. OneMedNet is trading at a lower price-to-earnings ratio than monday.com, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
73.7% of monday.com shares are owned by institutional investors. Comparatively, 0.9% of OneMedNet shares are owned by institutional investors. 22.3% of monday.com shares are owned by insiders. Comparatively, 46.2% of OneMedNet shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Analyst Recommendations
This is a summary of current recommendations and price targets for monday.com and OneMedNet, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| monday.com | 1 | 7 | 17 | 0 | 2.64 |
| OneMedNet | 1 | 0 | 0 | 0 | 1.00 |
monday.com presently has a consensus price target of $126.48, indicating a potential upside of 78.50%. Given monday.com’s stronger consensus rating and higher probable upside, analysts clearly believe monday.com is more favorable than OneMedNet.
Summary
monday.com beats OneMedNet on 12 of the 14 factors compared between the two stocks.
About monday.com
monday.com Ltd., together with its subsidiaries, develops software applications in the United States, Europe, the Middle East, Africa, the United Kingdom, and internationally. The company provides Work OS, a cloud-based visual work operating system that consists of modular building blocks used and assembled to create software applications and work management tools. Its products include monday work management that manages workflows, projects, and portfolios for team collaboration and productivity; monday sales CRM, whcih tracks and manages various sales cycle; monday dev that builds agile product and software development workflows; WorkCanvas, a digital whiteboard; and WorkForms, which allows users to create personalized forms or surveys and gain organizational insights. It serves organizations, educational or government institution, and distinct business unit of an organization. The company was formerly known as DaPulse Labs Ltd. and changed its name to monday.com Ltd. in December 2017. monday.com Ltd. was incorporated in 2012 and is headquartered in Tel Aviv, Israel.
About OneMedNet
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Receive News & Ratings for monday.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for monday.com and related companies with MarketBeat.com's FREE daily email newsletter.
